Suppressing β-catenin translocation to the nucleus through disruption of the interaction between BCL9 and β-catenin allows for disruption of oncogenic Wnt-signaling, resulting in tumor cell death and a pro-inflammatory tumor microenvironment – without disruption of homeostatic Wnt-function
ST316 suppresses transcription of Wnt target genes regulating proliferation, migration, invasion and the metastatic potential of tumor cells, as well as genes regulating the immunosuppression of the tumor microenvironment.

PHASE 2 DOSE EXPANSION ENROLLING
Recruitment of a Phase 2 dose expansion study is underway in patients with colorectal cancer.